Find Reports
Select Report Type
Reimbursement Review
Displaying 1201 - 1225 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | Open for Input | PH0086-000 | ||||||
| Solifenacin succinate / tamsul... | VesiFlow | Solifenacin succinate / tamsulosin hydrochloride | Benign prostatic hyperplasia | Withdrawn | SR0424-000 | ||||
| Teriparatide (rDNA origin) inj... | Forteo | Teriparatide (rDNA origin) injection | Osteoporosis | Withdrawn | SR0065-000 | ||||
| Ramipril/hydrochlorothiazide | Altace HCT | Ramipril/hydrochlorothiazide | Hypertension | Cancelled | SR0083-000 | ||||
| Tramadol hydrochloride | Zytram XL | Tramadol hydrochloride | Pain, acute | Withdrawn | SR0086-000 | ||||
| Atomoxetine hydrochloride | Strattera | Atomoxetine hydrochloride | Attention deficit hyperactivity disorder | N/A | Complete | SF0085-000 | |||
| Efalizumab | Raptiva | Efalizumab | Psoriasis, moderate to severe chronic plaque | N/A | Complete | SF0102-000 | |||
| Sodium oxybate | Xyrem | Sodium oxybate | Narcolepsy | Withdrawn | SR0107-000 | ||||
| Maraviroc | Celsentri | Maraviroc | HIV | Withdrawn | SR0113-000 | ||||
| Acamprosate calcium | Campral | Acamprosate calcium | Alcohol Abstinence | N/A | Complete | SF0143-000 | |||
| Tenofovir disoproxil fumarate | Viread | Tenofovir disoproxil fumarate | HIV infection | N/A | Complete | SF0139-000 | |||
| Teriparatide (rDNA origin) inj... | Forteo | Teriparatide (rDNA origin) injection | Osteoporosis | Withdrawn | SR0157-000 | ||||
| Insulin detemir | Levemir | Insulin detemir | Diabetes mellitus | Withdrawn | SR0158-000 | ||||
| Treanda-Rituximab for Chronic ... | Treanda (in combination with rituximab) | Bendamustine hydrochloride | Chronic Lymphocytic Leukemia | Withdrawn | PC0040-000 | ||||
| Voriconazole | VFEND | Voriconazole | Aspergillosis, Invasive | Withdrawn | SR0020-000 | ||||
| Mixed amphetamine salts | Adderall XR | Mixed amphetamine salts | Attention deficit hyperactivity disorder | Withdrawn | SR0027-000 | ||||
| Omalizumab | Xolair | Omalizumab | Asthma, severe persistent | Cancelled | SR0035-000 | ||||
| Escitalopram oxalate | Cipralex | Escitalopram oxalate | Depression, Major Depressive Disorder (MDD) | Withdrawn | SR0039-000 | ||||
| Pharmaceutical Reviews Update ... | |||||||||
| zanubrutinib | Brukinsa | zanubrutinib | Relapsed or refractory follicular lymphoma | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0037-000 | |||
| solriamfetol | Sunosi | solriamfetol | Excessive daytime sleepiness (narcolepsy) | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0038-000 | |||
| Pharmaceutical Reviews Update ... | |||||||||
| pembrolizumab | Keytruda | pembrolizumab | Primary mediastinal B-cell lymphoma | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0034-000 | |||
| olaparib | Lynparza | olaparib | Breast Cancer | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0013-000 | |||
| icatibant | Firazyr | icatibant | Acute attacks of hereditary angioedema | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0014-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1201 - 1225 of 2132
Please scroll or swipe to the right to view the full content.